Evidence map›Paper›PMID 37213035›Full record

ArticleDiscover oncology2023

Editorial Expression of Concern: Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles.

Murat Yalcin, Hung-Yun Lin, Thangirala Sudha, Dhruba J Bharali, Ran Meng, Heng-Yuan Tang, Faith B Davis, Steven C Stain, Paul J Davis, Shaker A Mousa

Abstract readExpression of Concern
In one paragraph

Article in Discover oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Murat Yalcin *Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, Albany, NY, 12208, USA.
Hung-Yun Lin *Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan.
Thangirala SudhaPharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, Albany, NY, 12208, USA.
Dhruba J BharaliPharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, Albany, NY, 12208, USA.
Ran MengPharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, Albany, NY, 12208, USA.
Heng-Yuan TangPharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, Albany, NY, 12208, USA.
Faith B DavisDepartment of Medicine, Albany Medical College, Albany, NY, 12208, USA.
Steven C StainDepartment of Surgery, Albany Medical College, Albany, NY, 12208, USA.
Paul J DavisPharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, Albany, NY, 12208, USA.
Shaker A MousaPharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, Albany, NY, 12208, USA. Shaker.Mousa@acphs.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37213035
PMCPMC10203060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.